Further, the expression of NK cell markers (NKG2D, NKp30, FASL, TRAIL, DNAM1, NKG2A, and PD1) from NK-GBM cells before and after co-culturing with the untreated (U87, U118, and U343 cells), Iri-treated, and Bev plus Iri-treated GBM cells are illustrated in Figure S4. The gene discussed is CD226; the disease is glioblastoma.